Alpha Financial Partners, LLC Danaher Corp Transaction History

Alpha Financial Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$224.58 - $256.19 $56,818 - $64,816	-253 Reduced 23.87%	807 $202 Million
Q4 2023 Jan 29, 2024	SELL	$185.1 - $233.13 $36,279 - $45,693	-196 Reduced 15.61%	1,060 $245 Million
Q3 2023 Nov 07, 2023	SELL	$233.08 - $265.59 $3,729 - $4,249	-16 Reduced 1.26%	1,256 $312 Million
Q2 2023 Jul 27, 2023	BUY	$224.99 - $256.14 $15,074 - $17,161	67 Added 5.56%	1,272 $305 Million
Q1 2023 May 10, 2023	BUY	$239.75 - $277.0 $8,151 - $9,418	34 Added 2.9%	1,205 $304 Million
Q4 2022 Feb 16, 2023	BUY	$241.42 - $282.29 $282,702 - $330,561	1,171 New	1,171 $311 Million

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Alpha Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Financial Partners, LLC with notifications on news.